Airport Personnel and Coronavirus Disease-2019: A Seroprevalence Study in Taiwan
DOI:
https://doi.org/10.17140/EMOJ-8-165Keywords:
COVID-19, Seroprevalence, Travel, Airport, WorkersAbstract
Introduction
Many countries tried to lifted the travel restriction to revive their stagnant tourism-based economies. However, infection risks among airport personnel are incompletely understood. We therefore conducted this seroepidemiological study targeting airport personnel.
Methods
This cross-sectional study was conducted from October 20th, 2020 to February 28th, 2021 at the Taoyuan International Airport in Taiwan. All adults who worked at Taoyuan International Airport and were older than 20-years of age were eligible for participation. Serological tests were collected and study participants were asked to complete an online questionnaire which collected self reported data including demographic characteristics, occupation, exposure risk assessment, recent symptoms, and self-perceived risk of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Continuous data were expressed with median and interquartile ranges; categorical data were expressed with counts and proportions.
Results
A total of 450 volunteers agreed to participate in the study. Most of the participants worked as ground crew (40.7%). Approximately 43.6% of participants did not feel any symptoms in the 3-months prior to serologic testing. Only 8 participants (1.8%) reported close contact with confirmed coronavirus disease-2019 (COVID-19) cases. Overall, none of the study participants had serologic confirmation of immunoglobulin G (IgG) antibodies against SARS-CoV-2.
Conclusion
The SARS-CoV-2 infection rate among airport personnel was low. This study demonstrates that a well-designed border control strategy may work and so that transmission of SARS-CoV-2 may be controllable.
References
Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wu-Submit your article to this journal | https://openventio.org/submit-manuscript/ 17 Lee C-C, et al han, China, of novel coronavirus–infected pneumonia. N Engl J Med. 2020; 382: 1199-207. doi: 10.1056/NEJMoa2001316
Williams CC. Impacts of the coronavirus pandemic on Europe’s tourism industry: Addressing tourism enterprises and workers in the undeclared economy. Int J Tour Res. 2021; 23: 79-88. doi: 10.1002/jtr.2395
Taiwan Centers for Disease Control (CDC). https://www.cdc. gov.tw/En. Accessed April 23, 2021.
Ng T-C, Cheng H-Y, Chang H-H, et al. Comparison of estimat-ed effectiveness of case-based and population-based Interventions on COVID-19 containment in Taiwan. JAMA Intern Med. 2021; 181(7): 913-921. doi: 10.1001/jamainternmed.2021.1644
Malagón-Rojas JN, Rubio V, Parra-Barrera E. Seroprevalence and seroconversions for SARS-CoV-2 infections in workers at Bo-gota Airport, Colombia, 2020. 2021; 28(4): taab006. J Travel Med. doi: 10.1093/jtm/taab006
Wajnberg A, Amanat F, Firpo A, et al. Robust neutralizing anti-bodies to SARS-CoV-2 infection persist for months. Science. 2020; 370: 1227-1230. doi: 10.1126/science.abd7728
Chen EY-T, Sachs MC, Dickman PW. No evidence of sub-stantial underreporting of COVID-19 deaths in Taiwan during 2020. J Formos Med Assoc. 2021; 120(9): 1788-1789. doi: 10.1016/j. jfma.2021.03.018 Original Research | Volume 8 | Number 1 |
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content published in Emergency Medicine (EM) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.
